Skip to main content
. 2008 Oct 22;3(10):e3474. doi: 10.1371/journal.pone.0003474

Figure 4. Assessment of myocardial function after ischemic injury and hESC-CM transplantation.

Figure 4

(a) Echocardiography demonstrates improved cardiac contractility (left ventricular fractional shortening, LVFS) following delivery of one million hESC-CMs compared to PBS injection alone at eight weeks post-transplant (P = 0.03). This was primarily due to improvement in left ventricular end systolic dimension (LVESD, middle) without significant changes in left ventricular end diastolic dimension (LVEDD, right). (b) Representative M-mode echocardiographic images from a mouse receiving hESC-CM transplantation (right panels) versus a mouse receiving a control PBS injection (left panels) at 4 (top panels) and 8 weeks (bottom panels). (c) Histological evaluation of infarct fibrosis reveals attenuation of scar in a representative animal treated with hESC-CMs (right panels) as compared with a representative animal receiving PBS alone (left panels) at 8 weeks post-transplantation. Masson's Trichrome stain (top panels) produces blue connective tissue and red muscle fibers to allow easy identification of the fibrotic scar resulting from ischemia reperfusion injury. Scale bars = 10 µm.